E Fund Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
E Fund Management's ABBV Position: Q2 2026 in Review
E Fund Management increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $153K and bringing the position to 22,856 shares worth $5.75M. The position accounts for 0.13% of the portfolio, ranked #81.
E Fund Management first reported a position in ABBV in Q1 2021 and has held it in 19 quarters since. The position peaked at $6.06M in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- E Fund Management held 22,856 shares of AbbVie worth $5.75M as of Q2 2026.
- E Fund Management bought 713 AbbVie shares in Q2 2026, an estimated $153K.
- AbbVie made up 0.13% of E Fund Management's portfolio in Q2 2026, its #81 holding.
- E Fund Management first reported a position in AbbVie in Q1 2021 and has held it in 19 quarters since.
- E Fund Management's AbbVie position peaked at $6.06M in Q1 2025.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.